Trials / Sponsors / OncoTherapy Science, Inc.
OncoTherapy Science, Inc.
Industry · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Phase I Study of Radiolabeled OTSA101-DTPA in Patients With Relapsed or Refractory Synovial Sarcoma Relapsed or Refractory Synovial Sarcoma | Phase 1 | 2020-01-10 |
| Recruiting | Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer Relapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast Cancer | Phase 1 | 2017-05-29 |
| Terminated | Pharmacological Study of Intravenous OTS167 in Patients With Refractory or Relapsed Acute Myeloid Leukemia, Ac AML, Advanced MDS, ALL | Phase 1 / Phase 2 | 2016-04-01 |
| Completed | Study to Evaluate Systemic Bioavailability of Oral OTS167 in Healthy Adult Subjects Healthy | Phase 1 | 2016-01-01 |
| Completed | Phase 1 Study of OTS167 in Patients With Solid Tumors Solid Tumors, Metastatic Tumors | Phase 1 | 2013-08-23 |